Related references
Note: Only part of the references are listed.Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Yongliang Zhang et al.
NATURE COMMUNICATIONS (2021)
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant Cases
Vincenzo Formica et al.
JOURNAL OF CLINICAL MEDICINE (2021)
ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
Mahendra Naidoo et al.
CANCERS (2021)
Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
Aitor Rodriguez-Casanova et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Leilani Lakemeyer et al.
DISEASES (2021)
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Michael L. Cheng et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients-Initial observations
Lotte Nygard et al.
PLOS ONE (2020)
Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study
G. M. Walls et al.
RADIATION ONCOLOGY (2020)
Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers
Takeyuki Suzuki et al.
Oncotarget (2020)
A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients
Francesco Cortiula et al.
DIAGNOSTICS (2020)
The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
D. Akhoundova et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients
Hangyu Zhang et al.
TRANSLATIONAL ONCOLOGY (2019)
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Mifanwy Reece et al.
FRONTIERS IN GENETICS (2019)
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie et al.
JAMA ONCOLOGY (2019)
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L. Liu et al.
ANNALS OF ONCOLOGY (2018)
Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
Shun-Ichiro Kageyama et al.
Oncotarget (2018)
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Francesco Sclafani et al.
SCIENTIFIC REPORTS (2018)
Evaluation of commercial kits for purification of circulating free DNA
Russell J. Diefenbach et al.
CANCER GENETICS (2018)
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
Francesco Passiglia et al.
SCIENTIFIC REPORTS (2018)
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
Suzanne Jenkins et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients
Grigoriy A. Yanus et al.
MEDICAL ONCOLOGY (2013)
Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
Uday Bharat Patel et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Frequency of KRAS, BRAF, and NRAS Mutations in Colorectal Cancer
Cecily P. Vaughn et al.
GENES CHROMOSOMES & CANCER (2011)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
